These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9157979)

  • 1. Potent pseudosubstrate-based peptide inhibitors for p60(c-src) protein tyrosine kinase.
    Lou Q; Leftwich ME; McKay RT; Salmon SE; Rychetsky L; Lam KS
    Cancer Res; 1997 May; 57(10):1877-81. PubMed ID: 9157979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design.
    Alfaro-Lopez J; Yuan W; Phan BC; Kamath J; Lou Q; Lam KS; Hruby VJ
    J Med Chem; 1998 Jun; 41(13):2252-60. PubMed ID: 9632358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the activity of pp60(c-src) protein tyrosine kinase inhibitors.
    Prabhu NV; Siddiqui SA; McMurray JS; Pettitt BM
    Biopolymers; 2001 Sep; 59(3):167-79. PubMed ID: 11391566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of potent and specific peptide inhibitors of p60c-src protein tyrosine kinase using pseudosubstrate-based inhibitor design approach.
    Kamath JR; Liu R; Enstrom AM; Lou Q; Lam KS
    J Pept Res; 2003 Dec; 62(6):260-8. PubMed ID: 14632929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and characterization of potential antineoplastic agents].
    Orfi L; Wáczek F; Szabó M; Kövesdi I; Mészáros G; Idei M; Horváth A; Hollósy F; Mák M; Szegedi Z; Szende B; Kéri G; Noszál B
    Acta Pharm Hung; 1999 Jun; 69(3):115-22. PubMed ID: 10401154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine kinases: structure, substrate specificity, and drug discovery.
    al-Obeidi FA; Wu JJ; Lam KS
    Biopolymers; 1998; 47(3):197-223. PubMed ID: 9817025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of cell-substrate adhesion activates the protein tyrosine kinase pp60(c-src).
    Maher PA
    Exp Cell Res; 2000 Nov; 260(2):189-98. PubMed ID: 11035913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold nanoparticle-based electrochemical detection of protein phosphorylation.
    Kerman K; Chikae M; Yamamura S; Tamiya E
    Anal Chim Acta; 2007 Apr; 588(1):26-33. PubMed ID: 17386790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic peptides as probes of the substrate binding site of the cytosolic tyrosine kinase, pp60c-src.
    McMurray JS; Budde RJ; Ke S; Obeyesekere NU; Wang W; Ramdas L; Lewis CA
    Arch Biochem Biophys; 1998 Jul; 355(1):124-30. PubMed ID: 9647675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of GIYWHHY as a novel peptide substrate for human p60c-src protein tyrosine kinase.
    Lou Q; Leftwich ME; Lam KS
    Bioorg Med Chem; 1996 May; 4(5):677-82. PubMed ID: 8804533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of efficient pentapeptide substrates for the tyrosine kinase pp60c-src.
    Nair SA; Kim MH; Warren SD; Choi S; Songyang Z; Cantley LC; Hangauer DG
    J Med Chem; 1995 Oct; 38(21):4276-83. PubMed ID: 7473555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of indole esters as inhibitors of p60(c-Src) receptor tyrosine kinase and investigation of the inhibition using receptor docking studies.
    Olgen S; Akaho E; Nebioglu D
    J Enzyme Inhib Med Chem; 2003 Dec; 18(6):485-90. PubMed ID: 15008512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D-QSAR studies on c-Src kinase inhibitors and docking analyses of a potent dual kinase inhibitor of c-Src and c-Abl kinases.
    Thaimattam R; Daga PR; Banerjee R; Iqbal J
    Bioorg Med Chem; 2005 Aug; 13(15):4704-12. PubMed ID: 15914012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reusable amperometric biosensor for measuring protein tyrosine kinase activity.
    Wang CL; Wei LY; Yuan CJ; Hwang KC
    Anal Chem; 2012 Jan; 84(2):971-7. PubMed ID: 22208917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding.
    Nam NH; Ye G; Sun G; Parang K
    J Med Chem; 2004 Jun; 47(12):3131-41. PubMed ID: 15163193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An increase in the expression and total activity of endogenous p60(c-Src) in several factor-independent mutants of a human GM-CSF-dependent leukemia cell line (TF-1).
    Horn S; Meyer J; Stocking C; Ostertag W; Jücker M
    Oncogene; 2003 Oct; 22(46):7170-80. PubMed ID: 14562045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Label-free electrical sensing of small-molecule inhibition on tyrosine phosphorylation.
    Kerman K; Vestergaard M; Tamiya E
    Anal Chem; 2007 Sep; 79(17):6881-5. PubMed ID: 17676818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of protein tyrosine kinase activity using a high-capacity streptavidin-coated membrane and optimized biotinylated peptide substrates.
    Schaefer EM; Guimond S
    Anal Biochem; 1998 Jul; 261(1):100-12. PubMed ID: 9683518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic peptidic substrate of minimal size and semioptimal sequence for the protein tyrosine kinase pp60c-src.
    Ramdas L; Obeyesekere NU; McMurray JS; Budde RJ
    Arch Biochem Biophys; 1996 Feb; 326(1):73-8. PubMed ID: 8579374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Src kinase inhibitory activity of a series of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles.
    Boschelli DH; Wu B; Ye F; Wang Y; Golas JM; Lucas J; Boschelli F
    J Med Chem; 2006 Dec; 49(26):7868-76. PubMed ID: 17181170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.